Arkolith/Insider Trading/CRVS/Form 4

Miller Richard A MD

President and CEO, DirectorCorvus Pharmaceuticals, Inc. (CRVS) · full profile →Form 4 · filed May 20, 2026
Net Buying
Open-Market Buys
$83K
Open-Market Sells
$0
Net Open-Market Flow
$83K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 18, 2026Buy(P)5K$12.05$60K1.2M
May 18, 2026Buy(P)2K$12.01$23K1.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000160) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML